Authors


Joel Lubar, MD

Latest:

Neurofeedback: Significance for Psychiatry

This article provides an overview of the role of neurofeedback as an intervention to target symptoms associated with psychiatric disorders.


Joel Paris, MD

Latest:

Locating Environmental Factors in Mental Disorders Within a Biopsychosocial Model

What are the connections between environmental factors and the development of mental disorders?


Joel T. Nigg, PhD

Latest:

Mini Quiz: Effects of Lead Exposure on Children

What potential clinical and medical effects of lead exposure remain today?


Joel Yager, MD

Latest:

Psychiatry in the Year 2500: Lessons Learned From History

What will psychiatric practice look like in the future?


Johan Verhulst, MD

Latest:

Undecidable Choices and the Polarization of Shared Ambivalence: What Can Psychiatry Add to Dispute Resolution?

Reframing is being tested as a potentially viable way to address intractable conflict where sacred values are at issue. In memory of Johan Verhulst, MD.


Johanna S. Kaplan, PhD

Latest:

Mental Health as a Role in Mortality Rates in Peri- and Postpartum Black Women

Black mothers in the US experience far worse outcomes. Here’s what clinicians need to know.


John F. Lauerman

Latest:

Is Redefinition of Psychiatry Underway?

Over the past decade, cost containment efforts have pushed psychotherapy patients away from psychiatrists and toward the offices of psychologists, therapists and other less expensive mental health workers. The availability of new drug treatments for psychiatric disorders has shifted many psychiatrists' practices away from a long-term therapeutic focus to that of short-term drug treatment. If psychiatry merely reacts to these economic and political forces, rather than managing them with a plan, the future of the field is highly uncertain.


John A. Fromson, MD

Latest:

Evolving Potential of Mobile Psychiatry: Current Barriers and Future Solutions

How will mobile mental health technologies change the nature of the psychiatrist-patient relationship? And do these technologies truly deliver what they promise?


John C. Erickson III

Latest:

What is the Market Rate for My Specialty?

The good news is that several resources provide guidance regarding market compensation. Here’s how that information will help you.


John D. Otis, PhD

Latest:

Psychiatry and Chronic Pain

Although acute pain typically resolves on its own with little need for intervention, for some persons pain persists past the point where it is considered an adaptive reaction to injury.


John D. Snook, JD

Latest:

4 Myths About Assisted Outpatient Treatment

After lounging on the doorstep of respectability for the past decade, assisted outpatient treatment is here to stay. But some still balk at the notion.


John Dequardo, MD

Latest:

Neuroanatomic Abnormalities

The first magnetic resonance imaging studies in schizophrenia began to appear in the literature in 1984. These studies confirmed earlier theories and also contributed new findings such as changes in size of the hippocampus, amygdala, corpus callosum and so on in patients with schizophrenia. What other neuroimaging techniques are being used? What do recent studies show regarding the neuroanatomic abnormalities found in patients with schizophrenia?


John E. Dunne, MD

Latest:

New Risks to Confidentiality in the Modern Era

While this article highlights some of the modern-era risks to confidentiality that psychiatrists may experience, it does not constitute an exhaustive list of issues to consider and is not a substitute for legal advice.


John E. Schowalter, MD

Latest:

Advances and Achievements

With the increase in child and adolescent patients comes an increase in challenging cases. Dr. Schowalter introduces this Child and Adolescent Psychiatry Special Report and provides perspective on articles discussing approaches to initiating care with a teen-ager, collaborating with pediatricians and other clinical topics.


John F. Alston, MD

Latest:

The Complex Issue of Attachment Disorders

Attachment may be defined as a composite of behaviors in an infant, toddler, or young child that is designed to achieve physical and emotional closeness to a mother or preferred caregiver when the child seeks comfort, support, nurturance, or protection.


John F. Curry, PhD

Latest:

Cognitive-Behavioral Therapy for Adolescent DepressionProcesses of Cognitive Change

The substantial and often recurrent distress and impairment associated with major depressive disorder (MDD) in youth has prompted increased interest in the identification and dissemination of effective treatment models. Evidence supports the use of several antidepressant medications, specific psychotherapies, and, in the largest treatment study of depressed teenagers, the combination of fluoxetine and cognitive-behavioral therapy (CBT) as effective treatments.1-3 CBT is the most extensively tested psychosocial treatment for MDD in youth, with evidence from reviews and meta-analyses that supports its effectiveness in that population.3-5


John G. Gunderson, MD

Latest:

Treatment Resistance in a Woman With Borderline Personality Disorder

Patients with borderline personality disorder or narcissistic personality disorder (or both) can feel entitled to special treatment and often seek only approving forms of attention from those who treat them.


John H. Fanton, MD

Latest:

Psychiatric Issues for Patients With Renal Disease

Currently, there are 350,000 Americans who receive maintenance dialysis for renal failure, and this predominantly elderly population with multiple comorbidities is growing.


John H. Halpern, MD

Latest:

Addiction Is a Disease

Addiction-as-disease or addiction-as-choice may be better defined by delineating initial experimentation with addictive drugs from ongoing drug use. Repeated exposure to addictive substances changes the molecules and neurochemistry of the addict. Addiction-as-disease accepts the responsibility of the health care professional to treat the patient and precludes the stigmatization that addiction is a choice.


John H. Krystal, MD

Latest:

Treating Agitation: A New FDA Approval

How is this new drug going to help in the treatment of agitation in patients with schizophrenia or bipolar disorder?


John H. Menkes, MD

Latest:

Neurological Complications of Perinatal Asphyxia

The degree of asphyxia is best ascertained by measuring the amount of fetal acidosis determined by umbilical arterial blood. An umbilical arterial pH of less than 7.0 is seen in about 0.3% of deliveries.1 It indicates a severity of acidosis that places the fetus at risk for permanent neurological damage because of asphyxia. However, the outcome of infants with umbilical cord pH of less than 7.0 who required neonatal intensive care is relatively good. Eighty-one percent can be expected have a normal examination at discharge.


John H. Sladky, MD

Latest:

Management of Mild Traumatic Brain Injury

A considerable overlap exists between TBI and disorders in cognition, behavior, and personality, which can provide even greater clinical challenges. More than 70% of the cases of TBI are mild, which makes this subgroup of particular clinical interest.


John J. Campbell III, MD

Latest:

Clinical Assessment of Dysexecutive Syndromes

Dysexecutive syndromes result from damage to the anterior regions of the brain and present as a combination of disinhibition, disorganization, or apathy.


John J. Campbell, III, MD

Latest:

Let’s Talk About Cognition

Cognitive problems have historically been the last to be recognized and treated in the clinical setting.


John J. Collins, MD

Latest:

Cerebral Palsy: A Multisystem Review

Cerebral Palsy: A Multisystem Review


John J. Medina, PhD

Latest:

The Molecular Biology of Weight Loss: An Unexpected Linkage Between 2 Molecules

This article outline a previously undescribed mechanism for understanding the molecular relationships between the hypothalamus and high-fat diets. Do they also hint at the creation of a fat pill?


John J. Miller, MD

Latest:

Medication-Assisted Psychotherapy: Moving Forward

The FDA did not vote to deny approval of MDMA-assisted psychotherapy on June 4, 2024, contrary to all the buzz in the media saying they did. Learn more here.


John J. Spollen, MD

Latest:

Posttraumatic Stress Disorder in Veterans

There have been nearly 1.5 million military deployments to the southwest Asian combat zone since the start of the Afghanistan operation and Iraq war in 2001 and 2003, respectively. There have been many casualties, some of which have been highly profiled, such as service members being killed in action, losing limbs, or suffering blast injuries to their brain.


John Kennedy, MD

Latest:

Assessing Violence Risk in Psychiatric Inpatients: Useful Tools

Psychiatrists who work in inpatient units are faced with daily decisions about predicting which patients will be violent, both in the hospital and after discharge. These decisions are often made using unstructured clinical judgment based on the clinician's experience and knowledge of the literature. How long such judgment stays the standard of care remains to be seen, because psychiatric researchers have produced a number of assessment and management tools to improve the accuracy and use of violence risk assessment. This article briefly outlines 3 tools: the Brøset Violence Checklist (BVC), the Classification of Violence Risk (COVR), and the Historical Clinical Risk-20 (HCR-20).


John Liebert, MD

Latest:

No Legal Exit: The Fort Hood Shooter

Army psychiatrist MAJ Nidal Hasan sought to get out of the service, but the Army, which had poured hundreds of thousands of dollars into his military and medical training, offered him no legal exit.

© 2024 MJH Life Sciences

All rights reserved.